Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
Recruiting · NCT07106359 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Alabama at Birmingham
View the official record on ClinicalTrials.gov →Interventions studied
Information LetterInformation Letter and Booklet
What this trial is about
The purpose of the study is to see if our education materials help people at risk for Lynch syndrome decide about seeking genetic services. Untested relatives of patients with Lynch syndrome will be recruited to complete a baseline survey and will be randomized to receive either the an information letter or an information letter plus a booklet. Two follow-up surveys will be administered over the span of 6 months. Participants will also be invited to join an optional exit interview to provide feedback.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- English speaking
- at least 18 years old
- have had genetic testing for Lynch syndrome (LS)
- do not have a condition that would interfere with their ability to provide informed consent and complete study activities (e.g., cognitive dysfunction evaluated using clinical judgment during screening)
- Clinical Trial Participants Inclusion Criteria:
- English-speaking
- at least 18 years old
- a blood relative of a patient who was diagnosed with LS
- potentially at risk for LS
- have not scheduled or had pre-test genetic counseling or genetic testing for LS
- do not have a personal history of a cancer (excluding non-melanoma skin cancer)
- do not have a condition that would interfere with their ability to provide informed consent and complete study activities (e.g., cognitive dysfunction evaluated using clinical judgment during screening)
Where it is running
1 location listed across 1 US state.
Read the full protocol, contacts and eligibility on ClinicalTrials.gov →